| European Federation of Internal Medicine

European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News

Type: News Feed

Palliative Care of End-Organ Disease in Patients with Multimorbidity

Submitted by claudine.buys on 20 October 2026 - 10:12

To register for this webinar, please click below:
Palliative Care of End-Organ Disease in Patients with Multimorbidity

The EFIM Multimorbidity Working Group is pleased to invite you to our upcoming Autumn Webinar on Palliative Care of End-Organ Disease in Patients with Multimorbidity, taking place on Thursday, 19 November at 19:00 CET.

Read more about Palliative Care of End-Organ Disease in Patients with Multimorbidity

European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) annual surveillance reports

Submitted by Anonymous (not verified) on 19 October 2026 - 16:47

European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) annual surveillance reports

Read more about European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) annual surveillance reports

Terms of reference for the European Sales and Use of Antimicrobials for veterinary medicine (ESUAvet) network

Submitted by Anonymous (not verified) on 19 October 2026 - 16:40

Terms of reference for the European Sales and Use of Antimicrobials for veterinary medicine (ESUAvet) network

Read more about Terms of reference for the European Sales and Use of Antimicrobials for veterinary medicine (ESUAvet) network

Human medicines European public assessment report (EPAR): Spectrila, asparaginase, Date of authorisation: 14/01/2016, Revision: 7, Status: Authorised

Submitted by Anonymous (not verified) on 19 October 2026 - 16:30

Human medicines European public assessment report (EPAR): Spectrila, asparaginase, Date of authorisation: 14/01/2016, Revision: 7, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Spectrila, asparaginase, Date of authorisation: 14/01/2016, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 19 October 2026 - 16:25

Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 5, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): mNexspike, COVID-19 mRNA vaccine, Date of authorisation: 12/02/2026, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 19 October 2026 - 16:10

Human medicines European public assessment report (EPAR): mNexspike, COVID-19 mRNA vaccine, Date of authorisation: 12/02/2026, Revision: 1, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): mNexspike, COVID-19 mRNA vaccine, Date of authorisation: 12/02/2026, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Revision: 20, Status: Authorised

Submitted by Anonymous (not verified) on 19 October 2026 - 16:05

Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Revision: 20, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Delstrigo, doravirine,lamivudine,tenofovir disoproxil, Date of authorisation: 22/11/2018, Revision: 15, Status: Authorised

Submitted by Anonymous (not verified) on 19 October 2026 - 15:56

Human medicines European public assessment report (EPAR): Delstrigo, doravirine,lamivudine,tenofovir disoproxil, Date of authorisation: 22/11/2018, Revision: 15, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Delstrigo, doravirine,lamivudine,tenofovir disoproxil, Date of authorisation: 22/11/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 12, Status: Authorised

Submitted by Anonymous (not verified) on 19 October 2026 - 15:50

Human medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 12, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 12, Status: Authorised

European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Palliative Care of End-Organ Disease in Patients with Multimorbidity

European Sales and Use of Antimicrobials for Veterinary Medicine (ESUAvet) annual surveillance reports

Terms of reference for the European Sales and Use of Antimicrobials for veterinary medicine (ESUAvet) network

Human medicines European public assessment report (EPAR): Spectrila, asparaginase, Date of authorisation: 14/01/2016, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Capvaxive, pneumococcal polysaccharide conjugate vaccine (21-valent), Date of authorisation: 24/03/2025, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): mNexspike, COVID-19 mRNA vaccine, Date of authorisation: 12/02/2026, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Delstrigo, doravirine,lamivudine,tenofovir disoproxil, Date of authorisation: 22/11/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Pifeltro, doravirine, Date of authorisation: 22/11/2018, Revision: 12, Status: Authorised

Newsletters

Latest Newsletters

You are here

Newsletters

Latest Newsletters